Corealis is currently owned by ARCHIMED, through MED Platform II, since 2022.

When did ARCHIMED acquire Corealis?

ARCHIMED acquired Corealis in 2022 (active for 4 years).

Home/Companies/Pharma/Corealis

Corealis

Pharma·Canada·Active·4yr hold

Corealis is a pharma services company, headquartered in Canada.

Entry

2022

Hold

4yr

Status

Active

Est. EV

–

Investor

ARCHIMED

Key facts

HQCanada

SectorPharma Services

Founded in 2005 by three senior scientists, COREALIS Pharma is a Canadian provider of formulation development and clinical supply…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from MED Platform II

Other portfolio companies in the same fund.

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Apera Asset Management

Last updated April 2026 · Sourced from public filings